Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance, common (in shares) at Mar. 31, 2023   99,458,369            
Beginning balance at Mar. 31, 2023 $ 607,255 $ 10 $ 100 $ (71) $ 822,217 $ (41,945) $ (175,115) $ 2,059
Beginning balance, preferred (in shares) at Mar. 31, 2023     100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2023       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (8,399)           (8,179) (220)
Foreign currency translation (6,107)         (6,846)   739
Stock-based compensation expense 10,017       10,017      
Shares issued:                
Exercise of stock options (in shares)   378,507            
Exercise of stock options 731       731      
Issuance of restricted shares and vesting of restricted units (in shares)   449,781            
Acquisition of non-controlling interests in Fyber (3,751)       (1,173)     (2,578)
Payment of withholding taxes related to the net share settlement of equity awards (931)       (931)      
Ending balance, common (in shares) at Jun. 30, 2023   100,286,657            
Ending balance at Jun. 30, 2023 $ 598,815 $ 10 $ 100 $ (71) 830,861 (48,791) (183,294) $ 0
Ending balance, preferred (in shares) at Jun. 30, 2023     100,000          
Ending balance, treasury (in shares) at Jun. 30, 2023       758,125        
Beginning balance, common (in shares) at Mar. 31, 2024 102,118,932 102,118,932            
Beginning balance at Mar. 31, 2024 $ 213,932 $ 10 $ 100 $ (71) 858,191 (48,955) (595,343)  
Beginning balance, preferred (in shares) at Mar. 31, 2024 100,000   100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2024 758,125     758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income $ (25,156)           (25,156)  
Foreign currency translation (1,213)         (1,213)    
Stock-based compensation expense $ 8,424       8,424      
Shares issued:                
Exercise of stock options (in shares) 8,645 8,599            
Exercise of stock options $ 14       14      
Issuance of restricted shares and vesting of restricted units (in shares)   390,752            
Payment of withholding taxes related to the net share settlement of equity awards $ (48)       (48)      
Ending balance, common (in shares) at Jun. 30, 2024 102,518,283 102,518,283            
Ending balance at Jun. 30, 2024 $ 195,953 $ 10 $ 100 $ (71) $ 866,581 $ (50,168) $ (620,499)  
Ending balance, preferred (in shares) at Jun. 30, 2024 100,000   100,000          
Ending balance, treasury (in shares) at Jun. 30, 2024 758,125     758,125